Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  2002-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood.v99.6.2262PMID 11877310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia.

  2001cited by this paper
• Normal B Cells Express 51p1-Encoded Ig Heavy Chains That Are Distinct From Those Expressed by Chronic Lymphocytic Leukemia B Cells1

  2001influential reference
• Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma.

  2001cited by this paper
• Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features.

  2000cited by this paper
• The Inference of Antigen Selection on Ig Genes1

  2000cited by this paper
• Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia.

  2000cited by this paper
• Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

  1999cited by this paper
• VH gene family utilization in different B‐cell lymphoma subgroups

  1999cited by this paper
• Clonal rearrangements in childhood and adult precursor B acute lymphoblastic leukemia: a comparative polymerase chain reaction study using multiple sets of primers

  1999cited by this paper
• Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

  1999cited by this paper
• Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

  1998cited by this paper
• Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas.

  1998cited by this paper
• Similar characteristics of the CDR3 of VH1‐69/DP‐10 rearrangements in normal human peripheral blood and chronic lymphocytic leukaemia B cells

  1998cited by this paper
• Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.

  1997influential reference
• VH3-21 B Cells Escape from a State of Tolerance in Rheumatoid Arthritis and Secrete Rheumatoid Factor

  1995cited by this paper
• The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire.

  1994cited by this paper
• The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.

  1994cited by this paper
• Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage leukaemias.

  1991cited by this paper
• Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia.

  1989cited by this paper

• Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms

  2025cites this paper
• Insights into the pathogenesis and biology of chronic lymphocytic leukemia through analysis of its B-cell receptor

  2025influential citation
• Prognostic factors in chronic lymphocytic leukaemia – the old, the new and the future

  2025cites this paper
• 采用高通量测序技术鉴别免疫球蛋白重链可变区体细胞高突变复杂克隆背景的研究

  2025cites this paper
• The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia

  2024cites this paper
• B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy

  2024cites this paper
• 慢性淋巴细胞白血病中B细胞受体同型模式的生物学特征和临床意义

  2024cites this paper
• Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024.

  2024cites this paper
• B cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients.

  2023cites this paper
• Prognostic Markers in the Era of Targeted Therapies

  2023cites this paper
• Phenotypic heterogeneity in IGHV -mutated CLL patients has prognostic impact and identi fi es a subset with increased sensitivity to BTK and PI3K δ inhibition

  2023cites this paper
• Cost-Effectiveness Analysis of Rituximab for Chronic Lymphocytic Leukemia Using A Semi-Markovian Model Approach in R.

  2022cites this paper
• Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia

  2022cites this paper
• CD160 receptor in CLL: Current state and future avenues

  2022cites this paper
• Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study

  2022cites this paper
• Next-Generation Sequencing Revealed a Distinct Immunoglobulin Repertoire with Specific Mutation Hotspots in Acute Myeloid Leukemia

  2022cites this paper
• Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL

  2022cites this paper
• EXABS-176-CLL Clinical Significance of B-Cell Receptor Stereotype in CLL.

  2022cites this paper
• Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal—Results from a population-based cancer registry cohort study

  2021cites this paper
• Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin

  2021cites this paper
• Brief Report

  2021cites this paper
• Brief Report

  2021cites this paper
• The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia: Biological and Clinical Implications.

  2021cites this paper
• Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?

  2020cites this paper
• NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 4.2020

  2020cites this paper
• Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.

  2020cites this paper
• Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing

  2020cites this paper
• HLA allele repertoire in Russian chronic lymphocytic leukemia patients with an unfavorable prognosis

  2020cites this paper
• IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.

  2020cites this paper
• Reading the B cell receptor Immunome in Chronic Lymphocytic Leukemia: Revelations and Applications.

  2020cites this paper
• Репертуар HLA-аллелей у российских больных хроническим лимфолейкозом с неблагоприятным прогнозом

  2020cites this paper
• Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).

  2019cites this paper
• Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group

  2019cites this paper
• Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

  2019cites this paper
• Molecular pathogenesis of chronic lymphocytic leukaemia

  2019cites this paper
• Prognostic Markers

  2019cites this paper
• Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).

  2019cites this paper
• Case 7-2019: A 73-Year-Old Woman with Swelling of the Right Groin and Fever.

  2019cites this paper
• State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia

  2018influential citation
• Molecular Diagnostics in Hematologic Malignancies

  2018cites this paper
• Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Introduction-Definition, Diagnosis, Cell of Origin

  2018cites this paper
• Combined Influence of B-Cell Receptor Rearrangement and Somatic Hypermutation on B-Cell Class-Switch Fate in Health and in Chronic Lymphocytic Leukemia

  2018cites this paper
• Impact des anomalies moléculaires dans l'histoire naturelle de la leucémie lymphoïde chronique

  2018cites this paper
• Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.

  2018cites this paper
• Unravelling the role of the microenvironment in chronic lymphocytic leukaemia: T helper cell support of cancer cells

  2018cites this paper
• Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials

  2018cites this paper
• Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia

  2018cites this paper
• Chronic lymphocytic leukaemia

  2017cites this paper
• Recurrent Genetic Mutations in Lymphoid Malignancies

  2017cites this paper
• Immunogenetics of chronic lymphocytic leukemia

  2017cites this paper
• Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia

  2017cites this paper
• Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms

  2017cites this paper
• Nuevas aportaciones de la hibridación in situ fluorescente y el estado mutacional del gen de las cadenas pesadas de inmunoglobulinas para predecir el curso clínico de los pacientes con leucemia linfocítica crónica

  2017cites this paper
• Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes With Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients With Chronic Lymphocytic Leukemia From Senegal

  2017cites this paper
• Somatic Hypermutational Status and Gene Repertoire of Immunoglobulin Rearrangements in Chronic Lymphocytic Leukemia

  2017cites this paper
• Characterisation of genetic complexity in chronic lymphocytic leukaemia

  2017cites this paper
• Role of precision medicine in the treatment of chronic lymphocytic leukaemia

  2016cites this paper
• Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia.

  2016cites this paper
• Exploring next-generation sequencing in chronic lymphocytic leukemia

  2016cites this paper
• Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

  2016cites this paper
• Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.

  2016cites this paper
• Reappraising prognosis in chronic lymphocytic leukemia

  2016cites this paper
• Genomic and transcriptomic sequencing in chronic lymphocytic leukemia

  2016cites this paper
• The genetics of mature B-cell malignancies

  2016cites this paper
• Applications of next-generation technologies in the diagnosis of haematological diseases and cancer

  2016cites this paper
• El estado mutacional de las inmunoglobulinas en pacientes con leucemia linfocítica crónica: significado y pronóstico

  2016cites this paper
• Chromatin accessibility maps of chronic lymphocytic leukemia identify subtype-specific epigenome signatures and associated transcription regulatory networks

  2016cites this paper
• Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia

  2016cites this paper
• The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity

  2016cites this paper
• Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks

  2016cites this paper
• Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic Impact

  2016cites this paper
• Chronic lymphocytic leukemia immunoglobulins display bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation status.

  2016cites this paper
• 脾边缘区淋巴瘤患者IGHV突变状态分析

  2016cites this paper
• Identification of B cell antigen receptor epitopes of mantle cell lymphoma B cells

  2016cites this paper
• Biological and clinical characteristics of patients with chronic lymphocytic leukemia with the IGHV3-21 and IGHV1-69; analysis of data from a single center.

  2015influential citation
• Investigation into the efficacy of the anti-CD20 monoclonal antibody ofatumumab in chronic lymphocytic leukaemia

  2015cites this paper
• IGHV gene usage and mutational status in follicular lymphoma: Correlations with prognosis and patient age.

  2015cites this paper
• Clinical prognostic biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma.

  2015cites this paper
• NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ) ® Non-Hodgkin ’ s Lymphomas

  2015cites this paper
• Antigen Selection Shapes the T-cell Repertoire in Chronic Lymphocytic Leukemia

  2015cites this paper
• The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?

  2015cites this paper
• Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.

  2015cites this paper
• Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.

  2015cites this paper
• SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients

  2014cites this paper
• Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition

  2014cites this paper
• Ibrutinib, Obinutuzumab, Idelalisib, and Beyond: Review of Novel and Evolving Therapies for Chronic Lymphocytic Leukemia

  2014cites this paper
• Stereotyped B-cell receptors in chronic lymphocytic leukemia

  2014cites this paper
• Leucemialinfocíticacrónica delinfocitosB:unmodelo personalizado de valoración clínicaymolecular

  2014cites this paper
• Molecular genetic studies on Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia - with focus on prognostic markers

  2014cites this paper
• Targeted therapy and outcome in chronic lymphocytic leukemia

  2014cites this paper
• Pathology of indolent B-cell neoplasms other than follicular lymphoma.

  2014cites this paper
• Prognostic factors in chronic lymphocytic leukemia

  2014cites this paper
• Five important advances in hematopathology.

  2014cites this paper
• Comprehensive characterization of immunoglobulin gene rearrangements in patients with chronic lymphocytic leukaemia

  2014cites this paper
• Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution.

  2014cites this paper
• Prognostic Significance of the IgVH Mutation Status and Immunohistochemical Analysis of ZAP70 and CD38 in Bone Marrow Biopsies in Chronic Lymphocytic Leukemia

  2014cites this paper
• The role of the Kinin-Kallikrein System in chronic lymphocytic leukaemia

  2014cites this paper
• Targeted therapy and outcome in chronic lymphocytic leukemia

  2014cites this paper
• Nucleic Acids as Molecular Diagnostics in Hematopoietic Malignancies – Implications in Diagnosis, Prognosis, and Therapeutic Management

  2014cites this paper
• CD19-targeting CAR T Cells for Treatment of B Cell Malignancies : From Bench to Bedside

  2014cites this paper